JAK2 and inflammation: In addition, WEIF and its components, DCQA, ABL, and 6-methoxyluteolin, contribute to the inhibitory effect of WEIF on the level of the type 2 inflammatory marker periostin by suppressing JAK2-STAT3/6 activation in human bronchial epithelial cells, which ameliorates OVA-induced airway inflammation [23].